Professor Tony Mok, leader of the Hong Kong study of Pembrolizumab. Photo: K.Y. Cheng

Hong Kong professor takes lead on cancer immunotherapy trial

TOP PICKS

Professor Tony Mok, leader of the Hong Kong study of Pembrolizumab. Photo: K.Y. Cheng
READ FULL ARTICLE